Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts
Public ClinicalTrials.gov record NCT00499967. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Assessment of the Safety, Tolerability, and Activity of GS-9191 Ointment for the Treatment of External Genital and Perianal Warts Caused by Human Papilloma Virus Infection
Study identification
- NCT ID
- NCT00499967
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 202 participants
Conditions and interventions
Conditions
Interventions
- GS-9191 ointment Drug
- GS-9191 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- Jan 31, 2009
- Completion
- Feb 28, 2009
- Last update posted
- Apr 8, 2009
2007 – 2009
United States locations
- U.S. sites
- 25
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tucson | Arizona | 85710 | — |
| Not listed | Beverly Hills | California | 90211 | — |
| Not listed | Mission Viejo | California | 92691 | — |
| Not listed | San Francisco | California | 94114 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Santa Rosa | California | 95405 | — |
| Not listed | Vallejo | California | 94589 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Tampa | Florida | 33607 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | St Louis | Missouri | 63117 | — |
| Not listed | Las Vegas | Nevada | 89106 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Stony Brook | New York | 11794 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Tulsa | Oklahoma | 74105 | — |
| Not listed | Portland | Oregon | 97239 | — |
| Not listed | Greenville | South Carolina | 29605 | — |
| Not listed | Chattanooga | Tennessee | 37404 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Houston | Texas | 77058 | — |
| Not listed | San Antonio | Texas | 78217 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
| Not listed | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00499967, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2009 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00499967 live on ClinicalTrials.gov.